vfa
The vfa—the association of research-based pharmaceutical companies in Germany (in German: Verband der forschenden Pharma-Unternehmen in Deutschland)—represents the interests of 48 of the world's leading research-based pharmaceutical companies and over 100 subsidiaries and sister companies in healthcare, research and economic policy. The members of the vfa represent more than two thirds of the entire German pharmaceutical market. They ensure therapeutic progress in pharmaceuticals and safeguard the high standard of drug therapy.
As a supporting partner of INCATE—Incubator for Antibacterial Therapies in Europe—vfa works together with the DZIF on the development of new antibiotics and strategies against deadly infectious diseases. The focus of the cooperation within the INCATE consortium, in which the DZIF is an academic partner and founding member, lies on supporting and empowering innovators to take their projects and ideas out of academia and research and develop them into investment-ready companies.